Vincorion’s SENTINEL Role and €40M EU Grant Signal Long-Term Ambitions Amid Near-Term Stock Rout

Defence supplier Vincorion sees shares drop to €18.56 amid tight shareholder structure and cash flow concerns, despite double-digit revenue growth and a record order backlog.

Vincorion is placing a major bet on the future of military energy systems. The defence supplier is a key participant in the SENTINEL research programme, which aims to modernise power supply for combat operations and phase out fossil fuels. The European Defence Fund has awarded nearly €40 million to the project, which brings together 42 partners across 16 countries. Management views the initiative as a strategic gateway to future NATO procurement contracts.

That long-term narrative, however, is being drowned out by a brutal week on the market. The stock has shed roughly 16% in seven trading sessions, falling to €18.56 after another 4.27% drop on Tuesday. The all-time high of €22.58, set in early May, now looks distant. The relative strength index has sunk to 22.1 – deep in oversold territory and a clear signal of aggressive selling pressure.

The disconnect between solid operational momentum and a tumbling share price stems from an unusually tight shareholder structure. STAR Capital, the private equity backer, holds 47.5% of the equity and those shares are locked up until autumn 2026. With such a limited free float, even modest trading volumes trigger outsized moves. The annualised volatility stands at nearly 71%.

Operationally, the first quarter delivered double-digit growth across the board. Revenue leapt 40% to €69 million, driven by surging demand for vehicle systems and power-generation platforms as European rearmament accelerates. Adjusted operating profit rose 30% in parallel. Yet the adjusted EBIT margin contracted to 18.0%, landing at the bottom end of the full-year guidance range of 18% to 19%.

A more immediate concern is cash generation. Free cash flow swung to negative €7.1 million, weighed down by tax catch-up payments and heavy capital expenditure. Investment spending doubled to €2.1 million as the company expands capacity at three sites. Management insists this is part of the ramp-up phase and expects normalisation later.

Despite the cash drain, the board has reaffirmed its annual outlook. Revenue is expected to reach up to €320 million, backed by a record order backlog. Anchor investors Fidelity, Invesco and T. Rowe Price committed €105 million in purchase guarantees at the initial public offering, providing some counterweight to the potential selling pressure when STAR Capital’s lock-up expires in the autumn.

For now, the stock remains structurally vulnerable to sharp reversals. Full order books and a €40 million EU research grant are powerful long-term assets, but they cannot insulate the shares from the mechanics of a thin market. Until the lock-up cliff passes, every trade will continue to carry disproportionate weight.